130 related articles for article (PubMed ID: 9812214)
21. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.
Eisenberg I; Avidan N; Potikha T; Hochner H; Chen M; Olender T; Barash M; Shemesh M; Sadeh M; Grabov-Nardini G; Shmilevich I; Friedmann A; Karpati G; Bradley WG; Baumbach L; Lancet D; Asher EB; Beckmann JS; Argov Z; Mitrani-Rosenbaum S
Nat Genet; 2001 Sep; 29(1):83-7. PubMed ID: 11528398
[TBL] [Abstract][Full Text] [Related]
22. Familial inflammatory inclusion body myositis.
Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary inclusion-body myopathy].
Kucharz EJ
Przegl Lek; 1999; 56(11):735-8. PubMed ID: 10800587
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
25. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N
Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
[TBL] [Abstract][Full Text] [Related]
26. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex.
Scott AP; Laing NG; Mastaglia F; Needham M; Walter MC; Dalakas MC; Allcock RJ
J Neuroimmunol; 2011 Jun; 235(1-2):77-83. PubMed ID: 21543121
[TBL] [Abstract][Full Text] [Related]
27. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 1998 Nov; 10(6):530-42. PubMed ID: 9812213
[TBL] [Abstract][Full Text] [Related]
28. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: diseases of oxidative stress and aging?
Askanas V; Engel WK
Arch Neurol; 1998 Jul; 55(7):915-20. PubMed ID: 9678308
[No Abstract] [Full Text] [Related]
29. An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene.
Broccolini A; Pescatori M; D'Amico A; Sabino A; Silvestri G; Ricci E; Servidei S; Tonali PA; Mirabella M
Neurology; 2002 Dec; 59(11):1808-9. PubMed ID: 12473780
[No Abstract] [Full Text] [Related]
30. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.
Weihl CC; Baloh RH; Lee Y; Chou TF; Pittman SK; Lopate G; Allred P; Jockel-Balsarotti J; Pestronk A; Harms MB
Neuromuscul Disord; 2015 Apr; 25(4):289-96. PubMed ID: 25617006
[TBL] [Abstract][Full Text] [Related]
31. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes.
Mastaglia F; Price P; Walters S; Fabian V; Miller J; Zilko P
Neuromuscul Disord; 2006 Nov; 16(11):754-8. PubMed ID: 16934978
[TBL] [Abstract][Full Text] [Related]
32. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.
Needham M; James I; Corbett A; Day T; Christiansen F; Phillips B; Mastaglia FL
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1056-60. PubMed ID: 18258695
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and classification of sporadic inclusion body myositis (sIBM).
Catalán M; Selva-O'Callaghan A; Grau JM
Autoimmun Rev; 2014; 13(4-5):363-6. PubMed ID: 24424185
[TBL] [Abstract][Full Text] [Related]
34. Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex.
Kok CC; Croager EJ; Witt CS; Kiers L; Mastaglia FL; Abraham LJ; Garlepp MJ
Immunogenetics; 1999 Jun; 49(6):508-16. PubMed ID: 10380695
[TBL] [Abstract][Full Text] [Related]
35. Familial inclusion body myositis: a report on two Japanese sisters.
Tateyama M; Saito N; Fujihara K; Shiga Y; Takeda A; Narikawa K; Hasegawa T; Taguchi Y; Sakuma R; Onodera Y; Ohnuma A; Tobita M; Itoyama Y
Intern Med; 2003 Oct; 42(10):1035-8. PubMed ID: 14606722
[TBL] [Abstract][Full Text] [Related]
36. Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis.
Scott AP; Laing NG; Mastaglia F; Dalakas M; Needham M; Allcock RJ
J Neuroimmunol; 2012 Sep; 250(1-2):66-70. PubMed ID: 22732452
[TBL] [Abstract][Full Text] [Related]
37. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.
Badrising UA; Schreuder GM; Giphart MJ; Geleijns K; Verschuuren JJ; Wintzen AR; Maat-Schieman ML; van Doorn P; van Engelen BG; Faber CG; Hoogendijk JE; de Jager AE; Koehler PJ; de Visser M; van Duinen SG;
Neurology; 2004 Dec; 63(12):2396-8. PubMed ID: 15623710
[TBL] [Abstract][Full Text] [Related]
38. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
[TBL] [Abstract][Full Text] [Related]
39. Inclusion body myositis in twins.
Amato AA; Shebert RT
Neurology; 1998 Aug; 51(2):598-600. PubMed ID: 9710045
[TBL] [Abstract][Full Text] [Related]
40. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.
Needham M; Mastaglia FL
Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
